Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USPSTF Drops Opposition To Prostate Screening, Remains Skeptical

This article was originally published in The Gray Sheet

Executive Summary

The U.S. Preventive Services Task Force will no longer recommend against routine prostate cancer screening, but cautions that the benefits have not been fully demonstrated

You may also be interested in...



PSA testing

Study published in May 28 New England Journal of Medicine concludes that isolated rises in prostate-specific antigen levels should be confirmed with a follow-up test before recommending prostate biopsy. James Eastham, MD, et al., Polyp Prevention Trial Study, note that the protocol "may reduce the number of unnecessary procedures markedly." While PSA testing combined with digital rectal exam often is used for early cancer detection, the U.S. Preventive Services Task Force does not endorse the procedure (1"The Gray Sheet" Dec. 9, 2002, p. 14)...

PSA testing

Study published in May 28 New England Journal of Medicine concludes that isolated rises in prostate-specific antigen levels should be confirmed with a follow-up test before recommending prostate biopsy. James Eastham, MD, et al., Polyp Prevention Trial Study, note that the protocol "may reduce the number of unnecessary procedures markedly." While PSA testing combined with digital rectal exam often is used for early cancer detection, the U.S. Preventive Services Task Force does not endorse the procedure (1"The Gray Sheet" Dec. 9, 2002, p. 14)...

Cancer Test Trials: EU Screening Plan Envisions Proxy Endpoint Recognition

The European Commission is considering adding further diagnostic cancer screens to the testing it supports in a recently announced call for member states to establish early detection programs

Related Content

UsernamePublicRestriction

Register

MT017607

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel